MIRA INFORM REPORT

 

 

Report Date :

23.04.2008

 

 

IDENTIFICATION DETAILS

 

Name :

HA TINH PHARMACEUTICAL & MEDICAL EQUIPMENT JOINT STOCK COMPANY

 

 

Registered Office :

No. 167, Ha Huy Tap Street, Ha Tinh City, Ha Tinh Province

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2007

 

 

Date of Incorporation :

1960

 

 

Com. Reg. No.:

2803000164

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacturing and Trading Pharmaceutical Products, Cosmetic, Chemical, Medicine and Trading Medical Materials and Equipments

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

SUBJECT IDENTIFICATION & LEGAL FORM

 

English Name
 
HA TINH PHARMACEUTICAL & MEDICAL EQUIPMENT JOINT STOCK COMPANY

Vietnamese Name

 

CONG TY CO PHAN DUOC VA THIET BI Y TE HA TINH

Shortened name

 

HATIPHARCO

Type of Business

 

Joint stock company

Founded

 

1960

Business Registration

 

2803000164

Issuance on

 

December 29th, 2004

Issuance by

 

Planning and investment department of Ha Tinh Province

Current registered capital

 

12,500,000,000 VND

Former Registered capital

 

5,500,000,000 VND

Tax code

 

0300104879

Total Employees

 

400 employees

 

 

ADDRESSES

 

Head Office and factory:

Address

 

No. 167, Ha Huy Tap Street, Ha Tinh City, Ha Tinh Province

Country

 

Vietnam

Tel

 

(84-39) 892549/ 858447/ 858114/ 858115/ 856605/ 854617

Fax

 

(84-39) 856821

Email

 

htp@hatipharco.com.vn

Website

 

www.hatipharco.com.vn

 

Hanoi Office:

Current Address

 

No. 3, Lane 122, Lang Street, Hanoi City

Business Registration No.

 

0113017865

Issuance on

 

June 1st, 2007

Issuance by

 

Planning and investment department of Hanoi City

Tax code No.

 

3000104879-011

Tel

 

84-4 8534872

Representative by law

 

Mr. Thieu Dang Hung

 

 

 

 

DIRECTORS

 

1. NAME

 

Mr. LE HONG PHUC

Position

 

Director / Chairman

Date of birth

 

May 11th, 1952

ID No

 

183522219

Issued on

 

September 26th, 2003

Issued by

 

Police station of Ha Tinh province

Resident

 

Tan Giang Ward, Ha Tinh City, Ha Tinh Province

Nationality

 

Vietnamese

Email

 

lehongphuc@hatipharco.com.vn

 

2. NAME

 

Mr. TRAN THAI SON

Position

 

Deputy director

Date of birth

 

July 1958

Nationality

 

Vietnamese

Email

 

tranthaison@hatipharco.com.vn

 

3. NAME

 

Mr. DAO VIET HUONG

Position

 

Deputy director

Date of birth

 

August 1959

Resident

 

Son Pho Commune, Huong Son District, Ha Tinh Province

Nationality

 

Vietnamese

Email

 

daoviethuong@hatipharco.com.vn

 

4. NAME

 

Mr. NGUYEN DANG PHAT

Position

 

Chief accountant

Resident

 

Cam Xuyen Townlet, Cam Xuyen District, Ha Tinh Province

Nationality

 

Vietnamese

Email

 

nguyendangphat@hatipharco.com.vn

 

 

BUSINESS NATURE AND ACTIVITIES

 

The subject registers and operates in manufacturing and trading pharmaceutical products, cosmetic, chemical, medicine and trading medical materials and equipments

 

 

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT: The subject imports materials and equipments for its production from China, India, Singapore and Thailand and some of EU countries

EXPORT: The subject exports its products  to ASEAN and East Western countries

 

 

BANKERS

 

1. BANK FOR INVESTMENT AND DEVELOPMENT-HA TINH BRANCH

Account No

 

52020000000286 (VND)

 

2. VIETCOMBANK-HA TINH BRANCH

Address

 

No. 11, Phan Dinh Phung Street, Ha Tinh City, Ha Tinh province

Country

 

Vietnam

Account No

 

0201370053528 (USD)

 

 

SHAREHOLDER(S)

 
The subject is a joint stock company. Following is its shareholders:

1. NAME

 

Mr. LE HONG PHUC

Position

 

Director / Chairman

Date of birth

 

May 11th, 1952

ID No

 

183522219

Issued on

 

September 26th, 2003

Issued by

 

Police station of Ha Tinh province

Resident

 

Tan Giang Ward, Ha Tinh City, Ha Tinh Province

Nationality

 

Vietnamese

Email

 

lehongphuc@hatipharco.com.vn

Current share

 

20,040 shares

Current Ratios

 

1.60 %

Former share

 

600 shares

Former Ratios

 

1.09 %

Note: Mr. Le Hong Phuc is also representative by law to hold current 310,200 shares account for  ratios of 24.80% (former: 165,000 shares-ratio: 30%) for state (managed by State Capital Investment Corporation)

 

 

 

 

 

2. NAME

 

Mr. DAO VIET HUONG

Position

 

Deputy director

Date of birth

 

August 1959

Resident

 

Son Pho Commune, Huong Son District, Ha Tinh Province

Nationality

 

Vietnamese

Email

 

daoviethuong@hatipharco.com.vn

Current share

 

13,780 shares

Current ratios

 

1.10%

Former Share

 

600 shares

Former Ratios

 

1.09 %

 

3. NAME

 

Mr. NGUYEN DANG PHAT

Position

 

Chief accountant

Resident

 

Cam Xuyen Townlet, Cam Xuyen District, Ha Tinh Province

Nationality

 

Vietnamese

Email

 

nguyendangphat@hatipharco.com.vn

Current share

 

19,860 shares

Current ratios

 

1.59%

Former Share

 

600 shares

Former Ratios

 

1.09 %

 

4. NAME

 

Mr. DINH VAN HUNG

Position

 

Shareholder

Resident

 

Nam Ha Ward, Ha Tinh City, Ha Tinh Province

Nationality

 

Vietnamese

Current share

 

15,190 shares

Current ratios

 

1.22%

Former Share

 

600 shares

Former Ratios

 

1.09 %

 

5. NAME

 

Mr. NGUYEN TRONG CU

Position

 

Shareholder

Resident

 

Nam Ha Ward, Ha Tinh City, Ha Tinh Province

Nationality

 

Vietnamese

Current share

 

13,780 shares

Current ratios

 

1.10%

Former Share

 

600 shares

Former Ratios

 

1.09 %

 

6. NAME

 

Mr. TRAN THAI SON

Position

 

Deputy director

Date of birth

 

July 1958

Nationality

 

Vietnamese

Email

 

tranthaison@hatipharco.com.vn

Current share

 

13,780 shares

Current ratios

 

1.10 %

Former Share

 

600 shares

Former Ratios

 

1.09 %

 

 

FINANCIAL DATA

 

Following is its audited financial statement which was collected from the subject

 

BALANCE SHEET

Unit: 1 VND

Balance sheet date

31/12/2007

31/12/2006

Number of weeks

52

52

ASSETS

A. Working assets & short-term Investment

60,866,668,007

33,660,034,852

I. Cash and cash equivalents

1,489,727,192

2,615,935,112

II. Short-term investment

0

0

 1. Short-term securities investment

0

0

 2. Other short-term investment

0

0

 3. Provision for short-term investment

0

0

III. Receivables

36,292,468,319

15,868,969,529

1. Receivables from customers

34,469,140,054

14,713,275,758

 2. Prepayment for providers

1,801761,370

1,051,621,097

 3. Value-added tax deducted

0

0

 4. Internal receivables

0

0

 5. Other receivables

21,566,895

104,072,674

 6. Provision for bad receivables

0

0

IV. Inventory

20,884,726,764

13,756,578,144

 1. Purchased goods in transit

0

0

 2. Raw materials

0

0

 3. Instrument, tools

0

0

 4. Cost for production and business in process

0

0

 5. End products

0

0

 6. Goods

20,884,726,764

13,756,578,144

 7. Goods on consignment

0

0

 8. Provision for devaluation of stocks

0

0

V. Other current assets

2,199,745,732

1,418,552,067

 1. Advances

0

0

 2. Prepaid expenses

1,384,250,682

1,161,318,568

 3. Pending expenses for transfer

0

0

 4. Pending assets

305,245,908

257,233,499

 5. Mortgage, collateral and short run collateral

510,249,142

 

VI. Administrative

0

0

 1. Administrative expenses for previous year

0

0

 2. Administrative expenses for current year

0

0

B. Fixed assets & Long term investment

15,895,126,415

12,906,766,167

I.  Fixed assets

15,662,326,415

11,541,749,437

1. Tangible fixed assets

15,662,326,415

11,541,749,437

   + Original cost

24,645,109,315

17,675,910,932

   + Accumulated depreciation value

-8,982,782,900

-6,134,161,495

2.  Financial leasing fixed assets

0

0

   + Original cost

0

0

   + Accumulated depreciation value

0

0

3. Intangible fixed assets

0

0

   + Original cost

0

0

   + Accumulated depreciation value

0

0

II. Long term investment

0

0

1. Long-term securities investment

0

0

2. Joint-venture capital contribution

0

0

3. Other long-term investment

0

0

4. Provision for long-term investment devaluation

0

0

III. Capital construction in process

232,800,000

809,851,522

IV. Other

0

555,165,208

TOTAL ASSETS

76,761,794,422

46,566,801,019

LIABILITES

A. Payable loans

57,696,981,628

40,133,043,997

I. Short term payables

48,164,886,272

31,487,222,421

1. Short-term borrowings

7,266,240,120

5,883,490,000

2. Due long-term liabilities

0

0

3. Payables to supplier

22,668,731,817

18,228,418,279

4. Prepayment of buyer

14,080,007,839

4,624,721,096

5. Taxes and accounts dutiable

51,499,238

61,382,290

6. Employee payments

1,033,241,226

606,976,218

7. Internal payables

348,139,580

103,419,062

8. Other payables

2,717,026,452

1,978,815,476

II. Long term loans

9,532,095,356

8,645,821,576

1. Long-term borrowings

9,003,504,699

8,429,615,699

2. Long-term payables

528,590,657

216,205,877

III. Other payables

0

0

1. Payable expenses

0

0

2. Pending assets

0

0

3. Receipts long-term collateral and deposit

0

0

B. Owner’s Equity

19,064,812,794

6,433,757,022

I. Capital and Funds

18,837,573,715

6,231,673,715

1. Working capital

12,500,000,000

5,500,000,000

2. Differences from asset revaluation

5,254,375,273

98,475,273

3. Exchange rate differences

0

0

4. Development investment funds

902,600,000

552,600,000

5. Reserved funds

180,598,442

80,598,442

6. Retained profit

0

0

7. Construction capital sources

0

0

II. Other administrative and fund sources

227,239,079

202,083,307

1. Provident funds for unemployment

0

0

2. Reward and welfare funds

227,239,079

202,083,307

3. Management funds of higher level

0

0

4. Functional operation funds

0

0

5. Fund sources formed by fixed assets

0

0

TOTAL LIABILITY AND EQUITY

76,761,794,422

46,566,801,019

 

 

 

 

 

 

 

 

 

 

 

 

PROFIT & LOSE ACCOUNT (INCOME STATEMENT)

 

Description

FY 2007

FY 2006

Total revenue

123,568,508,893

97,441,873,479

Deductions Items

2,386,638,165

1,097,082,430

- Discount

0

0

- Devaluation

0

0

- Return of sold goods

0

0

- Turnover tax, Luxury tax & Export tax

0

0

1. Net revenue

121,181,870,728

96,344,791,049

2. Cost of goods sold

102,019,995,985

82,168,402,156

3. Gross Profit

19,161,874,743

14,176,388,893

4. Sales expenses

11,795,141,379

8,613,255,247

5. Enterprise administrative expenses

5,114,180,125

3,871,926,865

6. Net income from business activities

2,252,553,239

1,691,206,781

Income from financial activities

934,400,322

518,528,120

Expenditure from financial activities

1,142,510,043

1,072,916,202

7. Net income from financial operation

-208,109,721

-554,388,082

Irregular income

107,380,952

0

Irregular expenditure

0

0

8. Irregular Profit

107,380,952

0

9. Total pre-tax profit

2,151,824,470

1,136,818,699

10. Income tax

150,290,166

0

11. After tax profit

2,001,534,304

1,136,818,699

 

 

FINANCIAL FACTORS

 

Description

FY 2007

FY 2006

Current Liquidity Ratio

1.26

1.07

Quick Liquidity Ratio

0.83

0.63

Inventory Circle

5.89

5.97

Average Receive Period

109.31

60.12

Utilizing Asset Performance

1.58

2.07

Liability / Total Asset (%)

75.16

86.18

Liability / Owner's Equity (%)

302.64

623.79

Income Before Tax / Total Asset (%) ROA

2.80

2.44

Income Before Tax / Owner's Equity (%) ROE

11.29

17.67

Income Before Tax / Total Revenue (%) NPM

1.74

1.17

Gross Profit / Total Revenue (%) GPM

15.51

14.55

 

 

CASH FLOW STATEMENT

 

Unit: 1 VND

Description

FY 2007

FY 2006

I. CASH FLOW FROM OPERATION ACTIVITIES

 

 

1. Pretax profit

2,151,824,470

1,136,818,699

2. Adjustments

 

 

- Fixed assets depreciation

3,011,228,547

2,414,717,232

- Lost/profit from investment operations

(107,380,952)

 

3. Profit from business activities before changing current assets

5,055,672,065

3,551,535,931

- Decreased/ increased receivables

(20,453,175,878)

(5,451,366,827)

- Decreased/ increased inventories

(7,157,457,979)

(2,031,026,350)

- Decreased/ increased payables (not included loan interest payable, income tax) 

15,387,900,496

8,960,617,002

- Decreased/ increased prepaid expense

231,186,537

(1,111,881,027)

- Loan interest paid

(1,142,510,043)

(1,072,916,202)

- Income tax paid

(109,289,092)

 

- Other income from business activities

 

 

- Other expenses for business activities

(170,021,500)

(129,362,910)

Net cash flow from operating activities

(8,357,695,394)

2,715,599,617

II. CASH FLOW FROM INVESTMENT ACTIVITIES

 

 

1. Expense for buying fixed assets and other assets

(6,951,853,524)

(1,615,239,557)

2. Receipts of interest, dividends

934,400,322

518,528,120

Net cash flow from investment activities

(6,017,453,202)

(1,096,711,437)

III. CASH FLOW FROM FINANCING ACTIVITIES

 

 

1. Payments for shares returns

11,957,900,000

 

2. Payment for shareholders

 

 

3. Receivable from short-term and long-term borrowings

44,793,396,310

43,305,292,146

4. Payment for principal borrowings

(42,836,847,190)

(44,307,059,586)

5. Payment for financial leasing

 

 

6. Payments for interest, dividend

(665,500,000)

(231,000,000)

Net cash flow from financial activities

13,248,949,120

(1,232,767,440)

Net cash flow in the period

(1,126,199,476)

386,120,740

Cash and cash equivalents at beginning of the period

2,615,935,112

2,229,814,372

Exchange rate differences

0

0

Cash and cash equivalents at the end of the period

1,489,735,636

2,229,814,372

 

 

PAYMENT HISTORY AND EXPERIENCES

 

Trade Morality

 

Fairly good

Liquidity

 

Above average

Payment status

 

Average

Financial Situation

 

Above average

Development trend

 

Fairly good

Litigation data

 

No recorded

Bankruptcy

 

No recorded

Payment Methods

 

Though its bank, L.C, T.T

Sale Methods

 

Through its agents over the country

 

 

INTERPRETATION ON THE SCORES

 

Ha Tinh Pharmaceutical and Medical Equipment Joint Stock Company was equitzed from state owned enterprise which is Ha Tinh Pharmaceutical and Medical Equipment Company. The subject was original found in 1960.

At the first period of operation (from 2005 to 2007), the subject has former registered capital of 5,5 billion VND, in which the private shareholders have 3,75 billion VND (hold 70% shares) and state owned 1,75 billion VND (hold left 30% shares).

After issuing more shares in May of 2007, the subject has increased its registered capital to 12,5 billion VND, in which private shareholders accounted 9,398 billion VND (hold 75.2% shares) and the state accounted 3,102 billion VND (hold 24.8% shares).

After being equitized, even the subject has changes in legal form but basically, the subject has still kept the manufacturing system, business operation, and infrastructure. Furthermore, the subject has to face up with disadvantages from the hard competitive environment, the fluctuation in material price, especially lack of pharmacist for studying, qualify managing and developing market share. In addition, its financial situation is still not as strong as foreign competitors to invest in processing GMP, GSP, GLP as enquiry from Ministry of Health.

Since year of 2004, the subject had borrowed money to invest in building medicine manufacturing factory and up to August of 2005, the GMP-ASEAN factory has been started operation making its capacity increased clearly.  

The subject is now trying its best to improve its image, manufacturing operation and financial situation to have more stable development in the future.

Its expected revenue in year of 2008 is 146 billion and after tax profit is 3 billion, dividend to shareholders is 15% to 16% per year, average earning for employees is 1,8 to 2 million VND per month, contribute to state 700 million VND and expense for research development is 500 million VND.

The subject is expected to rent 5 hectares land in Nam Cau Phu Industrial Zone to build a Oriental medicine factory in period year of 2008-2012, building a injectable drug factory with invested capital of 18 to 20 billion in 2008 and expected to started operation in 2010.

It is also expected to issue more stock to mobilize capital for production and trading as well as joining the stock market.

The subject company is expected to have better position in the industry when it is invested more and more to improve its production qualify and diversify products and expand market share.

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions